ORANGEVALE, Calif.--(BUSINESS WIRE)--

Biomagnetics Diagnostics Corp (Pinksheet: BMGP) announced today that they have signed a letter of Intent with Global Operational Resource Group (GORGRP).

Clayton Hardman states, "This acquisition starts our strategic program to provide strong revenue resources while developing our patented MTS-MTP diagnostics system. We are very excited about the growth potential of GORGRP and the services they provide. With ongoing negotiations and funding in place we expect to acquire additional firms providing minimum revenues of $20 million per year."

About Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary, Biospectrum Technologies, Inc. is a company that has patented revolutionary diagnostic equipment and highly specific and sensitive assays that are designed to be qualitative, (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective.

    www.biomagneticsbmgp.com

    About Global Operational Resource Group

Founded by former Special Forces personnel, it is dedicated to providing the highest quality medical service and instruction for those involved in operational environments. Medical field personnel and training cadre is comprised of Navy SEALs, Army Special Forces, SAS, DMAT/USAR, Federal & State LEO tactical/'operational GORGRP, Inc. is a firm that specializes in providing tactical, operational, and support personnel, training, and logistical services to military, government, and numerous international companies to provide both medical services and training in remote, high-hazard, and special threat medical care, SERE and personnel survival, and tactical rescue. With millions of dollars under contract and over 25 special operations medical & rescue personnel deployed throughout Iraq, Africa and the Balkans, Global is projected to create over $10,000,000 annual revenue and 22% EBITDA in year one of acquisition.

Forward Looking Statement:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performances of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Source: Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corp
Paul Hardman
 916-987-7078